ePrivacy and GPDR Cookie Consent by TermsFeed Generator

Detail of the clinical trial

Title of the trial A Phase 2 Study of IPI-145 in Subjects with Refractory Indolent Non-Hodgkin Lymphoma.
EudraCT number 2013-004008-20
Protocol number IPI-145-06
Sponsor Verastem, Inc., 117 kendrick Street, Suite 500, Needham, MA 02494, United States of America
Indications Hemato-oncology
Diagnosis non-Hodgkin Lymphoma
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Year of receiving the request to Institute (SÚKL) 2014
Date of approval by Institute (SÚKL) 12.9.2014
Date of approval by EC 9.7.2014
Date of initiation CT in ČR 12.12.2014
Date of ending CT in ČR 7.1.2019 (26.9.2018)
Sites Fakultni nemocnice Brno,Interni hematologicka a onkologicka klinika,Jihlavska 20,Brno,625 00
Fakultni nemocnice Ostrava,Klinika hematoonkologie,17. listopadu 1790,Ostrava,708 52
Fakultni nemocnice Kralovske Vinohrady,Interni hematoonkologicka klinika,Šrobárova 1150/50,Praha 10,100 34

‹‹ Back to list